Comerica Securities’s Chemed CHE Stock Holding History

Comerica Securities’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-81	Closed	-$41.3K	–	630
2022 Q4	$41.3K	Buy	+81	New	+$39.4K	﹤0.01%	761

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Comerica Securities's CHE Position: Q1 2023 in Review

Comerica Securities sold out of Chemed (CHE) in Q1 2023, closing a stake of 81 shares — an estimated $41.3K sold.

Comerica Securities first reported a position in CHE in Q4 2022 and held it in 1 quarter. The position peaked at $41.3K in Q4 2022. 459 funds tracked by Wall St. Rank hold CHE as of Q1 2023.

Comerica Securities reported no remaining Chemed position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 81 Chemed shares in Q1 2023, an estimated $41.3K.
Comerica Securities first reported a position in Chemed in Q4 2022 and held it in 1 quarter.
Comerica Securities's Chemed position peaked at $41.3K in Q4 2022.
459 funds tracked by Wall St. Rank held Chemed as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.